| 2024-02-21 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 3,365 0.0072% | $7.47 | $25,137 | +12.17% | |
| 2024-02-20 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 602 0.0013% | $7.68 | $4,623 | +13.21% | |
| 2024-01-17 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 1,266 0.0027% | $7.18 | $9,090 | +16.05% | |
| 2023-09-15 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 10,500 0.0245% | $8.16 | $85,680 | -1.88% | |
| 2023-07-06 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 5,500 0.0137% | $10.80 | $59,400 | -22.65% | |
| 2023-06-30 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 5,000 0.0123% | $11.41 | $57,050 | -27.95% | |
| 2023-02-17 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 738 0.0019% | $7.45 | $5,498 | +6.59% | |
| 2023-02-13 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 797 0.002% | $7.67 | $6,113 | +1.41% | |
| 2023-01-17 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 1,106 0.0031% | $9.85 | $10,892 | -12.6% | |
| 2023-01-06 | Sale | Voyager Therapeutics, Inc. VYGR | Chief Scientific Officer | 388 0.0009% | $6.41 | $2,487 | +15.8% |